首页 | 本学科首页   官方微博 | 高级检索  
     


Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Authors:A. Salihoglu  T. Elverdi  I. Karadogan  S. Paydas  E. Ozdemir  G. Erdem  N. Karadurmus  G. Akyol  L. Kaynar  ZA Yegin  G. Sucak  V. Ozkocaman  P. Topcuoglu  M. Ozcan  E. Birtas  H. Goker  Z. Baslar  B. Ferhanoglu
Affiliation:1. Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul University, Istanbul, Turkey
2. Division of Hematology, Antalya Medstar Hospital, Antalya, Turkey
3. Department of Internal Medicine, Division of Medical Oncology, Cukurova University, Adana, Turkey
4. Institute of Oncology, Stem Cell Transplantation Unit, Hacettepe University, Ankara, Turkey
5. Department of Internal Medicine, Gulhane Military Medical Academy, Division of Medical Oncology, Ankara, Turkey
6. Erciyes University, Department of Internal Medicine, Division of Hematology, Kayseri, Turkey
7. Department of Internal Medicine, Division of Hematology, Gazi University, Ankara, Turkey
8. Department of Internal Medicine, Division of Hematology, Uludag University, Bursa, Turkey
9. Department of Internal Medicine, Division of Hematology, Ankara University, Ankara, Turkey
10. Kocaeli University, Department of Internal Medicine, Division of Hematology, Kocaeli, Turkey
11. Hacettepe University, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
12. Koc University, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号